BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15337001)

  • 1. Clinical outcomes with the Hancock II bioprosthetic valve.
    Masters RG; Haddad M; Pipe AL; Veinot JP; Mesana T
    Ann Thorac Surg; 2004 Sep; 78(3):832-6. PubMed ID: 15337001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late results of heart valve replacement with the Hancock II bioprosthesis.
    David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes with the epicholorohydrin-modified porcine aortic heart valve: a 15-year follow-up.
    Wei X; Yi W; Chen W; Ma X; Lau WB; Wang H; Yi D
    Ann Thorac Surg; 2010 May; 89(5):1417-24. PubMed ID: 20417754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen-year results with the Hancock II valve: a multicenter experience.
    Rizzoli G; Mirone S; Ius P; Polesel E; Bottio T; Salvador L; Zussa C; Gerosa G; Valfrè C
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):602-9, 609.e1-4. PubMed ID: 16935116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-year results of the Hancock II bioprosthesis.
    Borger MA; Ivanov J; Armstrong S; Christie-Hrybinsky D; Feindel CM; David TE
    J Heart Valve Dis; 2006 Jan; 15(1):49-55; discussion 55-6. PubMed ID: 16480012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valve-related complications with the Hancock I porcine bioprosthesis. A twelve- to fourteen-year follow-up study.
    Bernal JM; Rabasa JM; Cagigas JC; Echevarria JR; Carrion MF; Revuelta JM
    J Thorac Cardiovasc Surg; 1991 May; 101(5):871-80. PubMed ID: 2023444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hancock II porcine bioprosthesis. A preliminary report.
    Bortolotti U; Milano A; Mazzucco A; Guerra F; Magni A; Santini F; Gallucci V
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):415-20. PubMed ID: 2918737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
    Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-year experience with the St Jude Medical mechanical valve prosthesis.
    Ikonomidis JS; Kratz JM; Crumbley AJ; Stroud MR; Bradley SM; Sade RM; Crawford FA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2022-31. PubMed ID: 14688722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than ten years' follow-up of the Hancock porcine bioprosthesis in Japan.
    Kawachi Y; Tanaka J; Tominaga R; Kinoshita K; Tokunaga K
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):5-13. PubMed ID: 1614215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
    Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical results of pericardial xenograft valves: the Ionescu-Shiley and Hancock valves.
    Goldman B; Scully H; Tong C; Mandell R; Butany J; Azuma J; Schwartz L
    Can J Cardiol; 1988 Sep; 4(6):328-32. PubMed ID: 3179796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Carpentier-Edwards SAV and Hancock-II porcine bioprostheses in aortic valve replacement.
    Jamieson WR; David TE; Feindel CM; Miyagishima RT; Germann E
    J Heart Valve Dis; 2002 May; 11(3):424-30. PubMed ID: 12056738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
    D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.